Seno Medical has secured an innovative technology contract with Vizient Inc for its Imagio breast imaging system, a groundbreaking device designed to enhance breast cancer diagnostics. The system combines opto-acoustic and ultrasound imaging to provide real-time, non-invasive insights into breast masses, aiming to reduce the need for invasive biopsies. According to GlobalData, a leading data and analytics firm, the Imagio breast imaging system marks a significant step forward in breast cancer diagnostics.

GlobalData projects that the global breast imaging market will reach $4.7 billion by 2025, driven by technological advancements and increasing awareness of breast cancer screening. As part of the broader diagnostic imaging market, expected to grow to $38.9 billion by 2027 at a 5.1% compound annual growth rate, the demand for advanced imaging technologies such as full-field digital mammography is a major growth factor.

Graysen Vigneux, medical analyst at GlobalData, states: “Seno Medical’s Imagio breast imaging system offers a revolutionary diagnostic solution that bridges the gap between traditional imaging methods and patient-centred care. By reducing the need for invasive biopsies, this technology improves both diagnostic precision and patient outcomes.”

The hybrid imaging technology of the Imagio system integrates functional and anatomical imaging to deliver real-time insights into tissue composition and blood vessel structures, providing a comprehensive view of breast masses. This non-invasive approach enhances diagnostic accuracy while minimising unnecessary procedures, in line with the growing emphasis on patient-centred care.

Vigneux concludes: “Breast cancer diagnostics has long been in need of innovation. The Imagio system not only transforms diagnostic workflows but also improves the patient experience by offering accurate, timely and less intrusive care. Seno Medical’s partnership with Vizient underscores the system’s potential to set a new standard in breast imaging technology, benefiting both patients and healthcare providers.”